Jennifer Repp

601 total citations
7 papers, 402 citations indexed

About

Jennifer Repp is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Jennifer Repp has authored 7 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Genetics. Recurrent topics in Jennifer Repp's work include Coronary Interventions and Diagnostics (4 papers), Cardiac Valve Diseases and Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jennifer Repp is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Cardiac Valve Diseases and Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Jennifer Repp collaborates with scholars based in Germany, United States and Italy. Jennifer Repp's co-authors include Salvatore Cassese, Adnan Kastrati, Robert A. Byrne, Sebastian Kufner, Heribert Schunkert, Massimiliano Fusaro, Jens Wiebe, Gjin Ndrepepa, Takeshi Kimura and Tareq Ibrahim and has published in prestigious journals such as The Lancet, Blood and JACC: Cardiovascular Interventions.

In The Last Decade

Jennifer Repp

5 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Repp Germany 4 372 253 143 95 25 7 402
Yuki Katagiri Netherlands 13 408 1.1× 302 1.2× 156 1.1× 173 1.8× 21 0.8× 43 471
Evangelia Vemmou United States 10 266 0.7× 178 0.7× 91 0.6× 138 1.5× 12 0.5× 42 314
Melissa Weissner Germany 12 495 1.3× 332 1.3× 167 1.2× 129 1.4× 15 0.6× 17 507
Pannipa Suwannasom Netherlands 15 581 1.6× 398 1.6× 214 1.5× 218 2.3× 20 0.8× 58 643
Jennifer Jones-McMeans United States 6 257 0.7× 209 0.8× 85 0.6× 41 0.4× 19 0.8× 6 282
Manuel Gómez-Recio Spain 6 266 0.7× 191 0.8× 118 0.8× 104 1.1× 17 0.7× 11 342
Michael Ball United States 8 419 1.1× 313 1.2× 141 1.0× 128 1.3× 12 0.5× 14 463
Amin Ariff Nuruddin Malaysia 7 348 0.9× 249 1.0× 90 0.6× 160 1.7× 27 1.1× 19 387
Aurélie Veugeois France 7 274 0.7× 214 0.8× 106 0.7× 111 1.2× 6 0.2× 22 329
Willem van der Giessen Netherlands 9 494 1.3× 268 1.1× 203 1.4× 222 2.3× 21 0.8× 14 525

Countries citing papers authored by Jennifer Repp

Since Specialization
Citations

This map shows the geographic impact of Jennifer Repp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Repp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Repp more than expected).

Fields of papers citing papers by Jennifer Repp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Repp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Repp. The network helps show where Jennifer Repp may publish in the future.

Co-authorship network of co-authors of Jennifer Repp

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Repp. A scholar is included among the top collaborators of Jennifer Repp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Repp. Jennifer Repp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Vachhani, Pankit, et al.. (2025). Early intervention with ruxolitinib improves spleen response in patients with myelofibrosis. Leukemia & lymphoma. 66(5). 981–984.
2.
Vachhani, Pankit, et al.. (2025). MPN-993: Clinical Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib and Anemia-Supporting Medications. Clinical Lymphoma Myeloma & Leukemia. 25. S683–S683.
3.
Vachhani, Pankit, et al.. (2024). Clinical Outcomes in Patients with Myelofibrosis Treated with Ruxolitinib and Anemia-Supporting Medications. Blood. 144(Supplement 1). 4546–4546. 1 indexed citations
4.
Kufner, Sebastian, Michael Joner, Simon Schneider, et al.. (2017). Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents. JACC: Cardiovascular Interventions. 10(13). 1332–1340. 100 indexed citations
5.
Kufner, Sebastian, Julinda Mehilli, Salvatore Cassese, et al.. (2016). Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents. JACC: Cardiovascular Interventions. 9(8). 784–792. 41 indexed citations
6.
Colleran, Róisín, Sebastian Kufner, Yukinori Harada, et al.. (2016). Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction. Catheterization and Cardiovascular Interventions. 89(3). 367–374. 8 indexed citations
7.
Cassese, Salvatore, Robert A. Byrne, Gjin Ndrepepa, et al.. (2015). Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. The Lancet. 387(10018). 537–544. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026